mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
-0.17 |
0.3 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.3 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.3 |